Alterations in NK cell numbers and function have been repeatedly shown during HIV infection. In this study, NK cell number and MHC class I expression on CD4+ T cells were studied in HIV patients at different stages of disease progression. An increased expression of HLA-E was seen on CD4+ T cells. In parallel, a reduced number of CD94+ NK cells was observed in advanced disease stages. Moreover, a decline in CD94 expression on NK cells was observed at the HIV replication peak in patients undergoing antiretroviral treatment interruption, suggesting a role of viral replication on NK cells alterations. In vitro HIV infection induced a rapid down-regulation of HLA-A,B,C expression, paralleled by an increased expression of HLA-E surface molecules, the formal ligands of CD94 NK receptors. HIV-infected HLA-E expressing cells were able to inhibit NK cell cytotoxicity through HLA-E expression, since cytotoxicity was restored by antibody masking experiments. These data indicate that the CD94/HLA-E interaction may contribute to NK cell dysfunction in HIV infection, suggesting a role of HIV replication in this process.
In contrast with adaptive responses, NK cells are able to kill virus-infected cells without prior antigen stimulation. They are also able to modulate the adaptive antigen-specific response by secreting cytokines and chemokines (1) (2) . NK cell function is tightly controlled by a network of inhibitory and activatory receptors (3) (4) . Expression ofMHC class I antigen allows the recognition of virus-derived peptides, thus eliciting antigen-specific cytotoxic T cell responses. The interaction of MHC class I protein with NK inhibitory receptors protects healthy cells from NK cytolysis, according to the 'missing "self" hypothesis (5) . Activator receptors instead allow NK cells to recognize danger signals after pathogen-induced modifications (6) (7) . Various viruses including HIV have evolved ways to subvert MHC-mediated inhibitory signals inducing a downregulation of MHC class I expression in virus-infected cells (8) . Specifically, HIV-I encoded Nef protein down-regulates HLA-A and -B molecules, but not the HLA-E and -G, thus preserving the NK inhibitory receptors signaling on infected cells (9) . HIV-positive patients show an up-regulation ofHLA-G molecule, a ligand for NK inhibitory receptors (10) . A direct involvement of NK cells in HIV infection progression is suggested by their reduction which correlates with the progression of infection to . Furthermore, the number ofNK cells increases during HAART-induced immune reconstitution, suggesting that HIV replication is directly involved in NK cell dysfunction (IS). Immune reconstitution is not able to induce a full recovery of NK cell functions (16) . Finally, a selective up-regulation ofCD94 lectin-like versus Iglike NK cell receptors was shown (17) (18) . CD94 is an heterodimer covalently linked to NKG2-AJB in its inhibitory form (19) . This complex was shown to bind to HLA-E (20), a class Ib molecule that bind peptides from the leader sequences of class la molecules (21) . Thus, HLA-E expression is thought to represent a sensor of "normal" HLA class I expression. In this study, we show that HLA-E expression is up-regulated both by HIV in vitro infection and during HIV disease progression, inhibiting the NK-mediated lysis of infected cells. These mechanisms may contribute to the immune evasion strategies of HIY.
MATERIALS AND METHODS

To observe changes in MHC class I expression during
HIV disease progression, a control group 8 HIV-persons subjects and a cohort of 51 HIV' subjects were studied (18 HIV' subjects with >500 CD4' T cells/ml; 23 HIV+ subjects with 200-500 CD4+ T cells/ml; 10 HIV' subjects with <200 CD4' T cells/ml). Each sample was evaluated using anti-HLA-E mAbs (lgGI, clone 3D12, courtesy of Dr. Miguel Lopez-Botet) and detected by a Goat anti-Mouse FITC (Pharmingen, Mountain View, CA). The other mAbs used were anti-CD56 (APC, IgG I, clone B159), anti-CD94 (FITC, IgG I, clone HP-3D9) from Becton-Dickinson Biosciences (Mountain View, CA), and anti-CD4 (PECy5, IgGI, clone 13B8.2, Beckman Coulter Immunotech, Miami, FL). Differences between groups were evaluated by the Mann-Whitney U test. P:'S 0.05 was considered to be significant.
To analyze the effect of acute HIV replication, we investigated the properties of NK cells in HIV-infected persons subjects showing a rapid plasma virus rebound after Structured Treatment Interruption (STI). Nine asymptomatic, but chronically HIV-I-infected patients were recruited from the National Institute for Infectious Diseases "Lazzaro Spallanzani" as previously described. Informed consent was obtained from patients. All clinical research experiments were performed using a protocol approved by the ethical committee of the Institute. The criteria for inclusion were as follows: more than two years of successful HAART, stable CD4+ counts (higher than 500 cell/ml for one year before study entry), undetectable HIV-RNA plasma levels (lower than 50 copies/ml by branched DNA assay [bDNA version 3.0, Bayer Diagnostics] for one year before entry), and HAART discontinuation for spontaneous request due to severe side effects. The patients underwent a single-cycle STI consisting of > I month of discontinuation. HAART reintroduction was decided upon according to the current guidelines on antiretroviral therapy. In these patients, a rapid HIV RNA rebound of >30,000 copies/ml was observed after 42.3±7.1 days. Clinical and immunological follow-up was done when HAART was suspended (TO), 1 month after suspension (Tl) and 1 month after HAART resumption (T2). At each time point ex vivo circulating NK cell phenotypes were determined by flow cytometry using anti-CD56 (APC, IgG I, clone B 159) and anti-CD94 (FITC, IgG I, clone HP-3D9) from Becton-Dickinson Biosciences (Mountain View, CA). Isotype-matched controls from Becton-Dickinson Biosciences were used in all experiments. For each sample, a total of 30,000 lymphocyte events were acquired by a FACS-Calibur instrument, and analyzed by Cell-Quest software (Becton-Dickinson Immunocytometry Systems, San Jose, CA). Additional ten healthy blood donors were used as controls.
To study MHC class I molecules modulation after HIV infection, susceptible CEM* I74.Tl and U937 cells (ATCC, Rockville, MD) at 105 cells/ml were infected using a HIV-I LA1 supernatant at 0.25 Multiplicity of Infection (MOl) in 10 ml complete medium (RPMI-1640). At the virus replication peak (24h), determined by HIV p24 level (ELISA, NEN Life Sciences), cells (Sxl Ovtube) were collected and stained by anti-HLA-A,B,C (FITC, IgG2., clone B9.12.1, Beckman Coulter Immunotech, Miami, FL) and anti-HLA-E (IgGl, clone 3D12, courtesy of Dr. Miguel Lopez-Botet, Barcelona, Spain), with detection by a Goat anti-Mouse FITC secondary antibody (Pharmingen, Mountain View, CA). After fixation in 500ml 1% paraformaldehyde in Phosphate-Buffered Saline (PBS), samples were immediately acquired by a FACS-Calibur instrument and analyzed by Cell-Quest software (Becton-Dickinson Immunocytometry Systems, San Jose, CA). Reference was made to uninfected control cultures.
To evaluate the effect ofHLA-E up-regulation on NKmediated cytotoxicity, uninfected and infected target cells (10 5 cells/O.S ml) were stained with 0.5 mM PKH-67 (Sigma, St.Louis, MO) for 2 mins at room temperature; cells were incubated in absolute FCS for I min and then treated with anti-HLAmonoclonal antibodies (1mg) (anti-HLA-E (IgG I, clone 3D12, courtesy of Dr. Miguel Lopez-Botet)). As a control, an anti-HLA-G antibody (IgG I, clone BF-4, courtesy of Dr. Miguel Lopez-Botetj) was used, since HLA-G expression is limited to human trophoblasts (23) , and was absent and not influenced by in vitro HIV infection on U937 cells (data not shown). Normal PBMC (10 5 cells/0.5 ml), used as a source ofNK cells, were added to target cells and incubated 16h in the presence of I mg/ml Propidium Iodide (PI) (Sigma, St-Louis, MO). Cells were acquired by a FACS-Calibur flowcytometer and analyzed by CellQuest software (Becton-Dickinson Immunocytometry Systems, San Jose, CA). PKH-67-gated target cells death was evaluated by PI staining, and expressed as percent cytotoxicity as described (24) . Any contribution of an aspecific ADCC mechanism was ruled out by the absence of anti-HLA -Einduced cytotoxicity using uninfected cells.
RESULTS
To evaluate the effects of HIV infection on CD4+ T-cell HLA-E expression, a cohort of 51 HIV+ chronically infected patients was studied at different stages of the disease. As shown in Figure 1A , an increased expression of HLA-E was found in all HIV+patient groups. Moreover, HLA-E expression levels on CD4 cells were associated with disease progression, suggesting an accumulation induced by HIV infection . To study how these changes correlate with NK phenotype in chronically infected patients , the frequency ofCD94+cells among CD56+NK cells was also studied. As shown in Figure IB , CD94 frequency also decreased in parallel with disease progression , suggesting a relationship between HLA-E expression and NK phenotype in chronically infected individuals . With the aim to understand how these changes correlate with the active HIV replication, CD94+ cell frequencies among CD56 + NK cells were studied in 10 HIV-persons compared to 9 HIV+ patients during antiretroviral treatment (TO), after one month of antiretroviral treatment interruption (Tl) and one month after antiretroviral treatment resumption (T2) ( Figure 1C ). An increased proportion of CD94+ NK cells was found at TO and T2 (p<O.05 vs. HIV-) . Interestingly, a significant decrease of CD94 expression was observed among CD56+ NK cells corresponding to the virus replication peak (T I) , suggesting a direct effect of HIV replication on NK cell phenotype.
To (Figure 2A , 2B) and MHC Class-l-like molecule (HLA-E) ( Figure Fig.  2C, 2D) Figures 3A, B, C,  D) . Thus, the influence ofHIVon HLAexpression of infected cells has two different effects: a) the reduction of class I molecule expression, and b) the parallel increase of class I-like molecule expression. This may represent an escape strategy used by HIV to overcome both CD8 and NK immune recognition.
To determine how the HIV-induced modulation of MHC molecules interferes with the recognition by NK cells, a model ofNK-specific cytotoxicity was developed, to measure ifHLA molecule masking by monoclonal antibodies may change NK effector function. Thus, an in vitro cytotoxicity test was setup using normal PBMC as effectors and susceptible cells (U937) as targets. Strong cytotoxic activity was shown by normal NK cells ( Figure 3E ) that could not be blocked by pre-treatment of target cells with monoclonal anti-HLA-E or anti-HLA-G antibodies. When target U937 cells were infected by HIV, a significant inhibition of NK-specific lytic activity was observed ( Figure. 3F) . Interestingly, this inhibition could be abrogated by pre-treating target cells with anti-HLA-E, but not with anti-HLA-G, antibodies. This finding suggests that HLA-E recognition may be the mechanism used to dispense a negative signal to NK cells. Overall, our results suggest that HIV infection induces HLA-E upregulation on target cells that, in tum, deliver an inhibitory signal to NK cells.
DISCUSSION
Due to their unique ability to kill infected cells without the need of a previous immunization, NK cells may be seen as a first line of defense against pathogens. They participate in early innate defense A Uninfected control B 24 hours after HIV 2,.----------, Fig. 3 . MHC Class-I molecule (HLA-A,B, C) (Figure 3A,  3B) and MHC Class-l-like molecule (HLA-E) ( Figure 3C , 3D) expression modulation in U-937 cells before (A, C) and 24h after (B, D) in vitro HIV-l LAJ infection. NKspecific cytotoxicity assay are also shown using uninfected ( Figure 3E ) and HIV-infected ( Figure 3F function through a) the cytotoxic ability to lyse pathogen-infected cells and b) the ability to release cytokines and chemokines that may modulate the antigen-specific acquired immune response (1-2). Their activation is the result of a carefully regulated network of inducing and inhibitory signals mediated by a variety of surface receptors (26) . These receptors recognize, among others, MHC Class-I and Class-Ilike molecules, so that the modulation of the expression of these molecules may result in an activation of the killing ability. In particular, the expression pattern of these molecules may be altered in cells sustaining a stress, such as an infection or tumor transformation, so that the relative net balance between activating and inhibitory signals may result in the triggering of NK killing ability. In particular, normal MHC Class-I-expressing cells engage inhibitory receptors on NK cells, thus avoiding NK cytolysis. Conversely, cells that have a decreased MHC Class-I expression are not able to inhibit, and become very sensible sensitive to, NK cells cytotoxicity. This phenomenon was initially described as the "missing self' hypothesis (5) . Several receptors have been described in humans, including Killer-cell Immunoglobulin-like Receptors (KIRs), Leukocyte Immunoglobulin-like Receptors (URs) and CD94INKG2A lectin-like receptors, which are characterized by the presence of an intracytoplasmic Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) that mediates their inhibitory effect upon engagement by MHC molecules (27) (28) . Different receptors recognize different MHC class-I molecules, such as HLA-A,B,C alleles for KIRs and HLA-E for CD94INKG2A receptors (28) . Interestingly, the expression of HLA-E is stabilized by binding peptides processed from leader sequences of other MHC Class-I molecules, thus signaling on the cell surface the overall status of MHC Class-I molecules (29) . Virus invaders, including HIV, developed mechanisms to evade both innate and specific cell responses, including selected downmodulation of MHC Class-I molecules expression (9) . In particular, HIV-Nef protein is able to disrupt MHC Class-I (HLA-A and -B), but not HLA-E trafficking (30) . In our model of in vitro HIV infection, a selective down-regulation of MHC Class-I molecules was observed, corresponding to the virus replication peak at 24 hours. Interestingly, we noticed a selective upregulation of HLA-E molecules, which could negatively influence NK cell regulation during HIV infection. Accordingly, in a cytotoxic assay, a specific inhibition corresponded to the increased expression of HLA-E molecules induced by HIV infection. Moreover, we observed an up-regulated expression of HLA-E molecules on CD4 cells (31) from HIVinfected patients that was associated to disease progression. Since the frequency of circulating HIVinfected CD4 cells (31) is lower than the frequency of HLA-E expressing CD4 T cells, the proinflammatory response (such as IFNi) induced by HIV infection could be responsible for the bystander HLA-A,B,C induction (32) and consequent HLA-E up-regulation.
NK cell number and function are both early affected after HIV infection (14) , and related to the progression of the disease (11, [33] [34] . Moreover, a specific regulation of CD94 lectin-like NK cell receptors, in comparison with Ig-like NKT cell receptors, was found in HIV-infected individuals (17) . Accordingly, we observed that CD94+CD56+ cell number significantly decreases in the later stages of disease progression, as described by others (17) . As expected, the decrease of NK cell number associated to the progression of the disease (13) includes cells carrying the CD94 receptor. Nevertheless, the percentage ofNK cells displaying CD94 receptor increases with the disease (17) (18) .
Accordingly, we observed that the CD94 expression among CD56+ cells was significantly increased in a situation of stable HIV-RNA level (due to HAART) before and after the STI period. Kottilil S. et al. recently showed a direct correlation between HIV viremia level and CD94 expression on NK cells (35) . In contrast, we observed an inverse correlation between CD94 expression and viremia at the time point corresponding to the acute HIV replication peak. This discrepancy may reflect an inherent difference between the clinical settings: a) patients with different, but stable HIV-RNA levels were previously analyzed (35) , whereas b) patients with an acute increase of HIV-RNA level are analyzed longitudinally in our study. Thus, CD94 expression among NK cells may increase in patients with higher, but stable viremia but rapidly disappear during an acute phase of viral replication. Another possibility is a dichotomy between activatory (CD94/NKG2C) and inhibitory (CD94/NKG2A) NK receptors. Further experiments are required to clarify this issue in HIV clinical settings.
Taken together, our data suggest a differential effect of acute and chronic HIV replication on both NK cells number and function, and on NK-lysissusceptibility of infected cells through the modulation of inhibitory signals. The HLA-E upregulation that we observed both in vitro and ex vivo during disease progression and HIV replication may represent a general mechanism to elude NK surveillance without the risk to increase the susceptibility to CTL recognition.
